20

Chemioterapia przedoperacyjna: zbiorcza analiza badań III fazy

	Ocmctficsńpy •*jro*y	SofOtfy akytm	O-E	Variance
Dautzenberg	13	13	0.12	3.55
Roth	28	32	-0.82	6.78
Rosell	30	30	-4.10	8.44
Depiarre	179	176	-10.99	58 25
JCOG 9209	31	31	-3.60	12.32
Sorensen	44	46	-1.19	10.61
SWOGS9900	168	167	-5.86	33.59
Tolał	493	495	-26.44	133.54

Hazard Ratio

chemotherapy+surgery bctter surgery alono better

Oyorall HR=0.82 (95% Cl 0.69-0.97), x⁷(i>^g5.235, p=0.02. Hot xW*1.14, p«0.98

Burdett. J Thoracic Oncol 2006; 1:611